Атеросклероз (Jun 2016)

HYPOLIPIDEMIC MEDICATIONS: CURRENT USE AND FUTURE PERSPECTIVES. PART 2. A COMMON APPROACHES FOR STATIN’S USING

  • A. E. Bagriy,
  • A. I. Dyadyk,
  • M. V. Khomenko,
  • I. N. Tsiba,
  • V. A. Efremenko,
  • E. V. Schukina,
  • O. A. Prikolota

Journal volume & issue
Vol. 12, no. 2
pp. 48 – 57

Abstract

Read online

This article is devoted to discussion about main aspects of current use of 3-hydroxy-3-methylglutaril CoA reductase inhibitors (statins) according last international guidelines. Statin’s base effects on lipid profile, medication regimens, side effects and safety ensuring are represented.

Keywords